Institutional Ownership
Artiva Biotherapeutics Inc
CUSIP 04317A107COMARTVQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
42.3%
Max % of class reported
Institutional Holders
38
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Jul 16, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 2.0% | 485.7K | SEC |
| 2 | May 15, 2025 | Venbio Global Strategic Fund III, L.P. | 13G/A | 4.9% | 1.20M | SEC |
| 3 | Apr 23, 2025 | Blackrock, Inc. | 13G | 5.1% | 1.25M | SEC |
| 4 | Nov 14, 2024 | Venbio Global Strategic Fund III, L.P. | 13G/A | 6.3% | 1.52M | SEC |
| 5 | Sep 3, 2024 | Ra Capital Management, L.P. | 13D/A | 40.6% | 9.85M | SEC |
| 6 | Aug 1, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G | 6.9% | 1.61M | SEC |
| 7 | Aug 1, 2024 | 5am Ventures Vi, L.P. | 13G | 5.0% | 1.17M | SEC |
| 8 | Aug 1, 2024 | Venbio Global Strategic Fund III, L.P. | 13G | 7.8% | 1.82M | SEC |
| 9 | Jul 29, 2024 | Gc Corp. | 13D | 19.6% | 4.57M | SEC |
| 10 | Jul 29, 2024 | Ra Capital Management, L.P. | 13D | 42.3% | 9.85M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 9.85M | $63.46M |
| 2 | 5am Venture Management, LLC | 2.35M | $15.16M |
| 3 | Venrock Adviser, LLC | 1.61M | $10.37M |
| 4 | Venbio Partners LLC | 531.3K | $3.42M |
| 5 | Franklin Resources Inc | 520.3K | $3.35M |
| 6 | Revelation Capital Management, LLC | 299.3K | $1.93M |
| 7 | Blackrock, Inc. | 213.4K | $1.37M |
| 8 | Wellington Management Group LLP | 194.1K | $1.25M |
| 9 | Propel Bio Management, LLC | 146.4K | $949.8K |
| 10 | Millennium Management LLC | 123.3K | $793.9K |